ABC transporter
From Proteopedia
(Difference between revisions)
Line 6: | Line 6: | ||
ABC Transporters have two main functionalities acting either as exporters or importers. '''ABC ''Exporters''''' release bound drugs to the extracellular environment, while '''ABC ''Importers''''' accept substrate molecules from their relevant substrate-binding proteins<ref name="biochembook"/>. For instance the Vitamin B12 transporter BtuCD (PDB [[1l7v]]) is a binding protein-dependent ABC transporter system that uses the power of ATP hydrolysis to pump vitamin B12 into the cytoplasm of E. coli<ref name="BtuCD-Ecoli"/>. | ABC Transporters have two main functionalities acting either as exporters or importers. '''ABC ''Exporters''''' release bound drugs to the extracellular environment, while '''ABC ''Importers''''' accept substrate molecules from their relevant substrate-binding proteins<ref name="biochembook"/>. For instance the Vitamin B12 transporter BtuCD (PDB [[1l7v]]) is a binding protein-dependent ABC transporter system that uses the power of ATP hydrolysis to pump vitamin B12 into the cytoplasm of E. coli<ref name="BtuCD-Ecoli"/>. | ||
- | |||
- | '''ABC Exporters''' use ATP to drive import and export functions providing multidrug resistance. In eukaryoles, for instance, ABC Transporters are problematic because they export therapeutic drugs such as those used in chemotherapy regimens, which must be changed frequently to avoid the rejection of the drugs<ref name="biochembook"/>. | ||
== Structural highlights == | == Structural highlights == | ||
Line 15: | Line 13: | ||
== Disease == | == Disease == | ||
- | There are currently 50 known ABC transporters in human. Of these there are 13 genetic diseases known to be associated with 14 of them. Among the diseases are cystic fibrosis, Stargardt disease, age-related macular degeneration and others. | + | There are currently 50 known ABC transporters in human. Of these there are 13 genetic diseases known to be associated with 14 of them. Among the diseases are cystic fibrosis, Stargardt disease, age-related macular degeneration and others. '''ABC Exporters''' use ATP to drive import and export functions providing multidrug resistance. In eukaryoles, for instance, ABC Transporters are problematic because they export therapeutic drugs such as those used in chemotherapy regimens, which must be changed frequently to avoid the rejection of the drugs<ref name="biochembook"/>. |
</StructureSection> | </StructureSection> | ||
Revision as of 10:46, 21 October 2015
|
3D Structures of ABC transporter
Updated on 21-October-2015
References
- ↑ 1.0 1.1 Huls et al. The Role of ATP Binding Cassette Transporters in Tissue Defense and Organ Regeneration. Journal of Pharmacology and Experimental Therapeutics, 2008; 328 (1)
- ↑ 2.0 2.1 2.2 Garrett R, Grisham CM. Biochemistry. 2008. 1059 pages
- ↑ 3.0 3.1 Linton KJ, Higgins CF. The Escherichia coli ATP-binding cassette (ABC) proteins. Mol Microbiol 28: 5–13, 1998
- ↑ 4.0 4.1 4.2 Linton KJ. Structure and Function of ABC Transporters. Physiology 22: 122-130, 2007; doi:10.1152/physiol.00046.2006
- ↑ 5.0 5.1 Borths EL. Structural and biochemical characterization of the vitamin B12 ABC transporter, BtuCD-F. Dissertation (Ph.D.), California Institute of Technology. 2005
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, Zina Saadi